| Bioactivity | Cefditoren Pivoxil (ME 1207) is a broad-spectrum, third-generation, oral cephalosporin antibacterial with enhanced stability against many common β lactamases. Cefditoren Pivoxil has activity against Gram-negative organisms and Gram-positive organisms. Cefditoren Pivoxil can be used in the research of infection diseases such as acute exacerbations of chronic bronchitis, community-acquired pneumonia (CAP), streptococcal pharyngitis/tonsillitis, or uncomplicated skin and skin structure infections[1][2]. | ||||||||||||
| Invitro | Cefditoren (Pivoxil) shows good activity against pneumoniae, S. pyogenes, Staphylococcus aureus, H. influenzae and H. parainfluenzae, M. catarrhalis[1]. Organism | ||||||||||||
| Name | Cefditoren (Pivoxil) | ||||||||||||
| CAS | 117467-28-4 | ||||||||||||
| Formula | C25H28N6O7S3 | ||||||||||||
| Molar Mass | 620.72 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Cefditoren (Pivoxil)
CAS: 117467-28-4 F: C25H28N6O7S3 W: 620.72
Cefditoren Pivoxil (ME 1207) is a broad-spectrum, third-generation, oral cephalosporin antibacterial with enhanced stabi
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.